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By manipulating an infectious cDNA clone of poliovirus, we have introduced a single-codon insertion into the
3A region of the viral genome which has been proposed to encode a functional precursor of the virion-linked
protein VPg. The resulting mutant was cold sensitive in monkey kidney cells. Viral RNA synthesis was poor at
32.5°C, although no other function of the virus was obviously affected. The synthesis of both positive and
negative strands was severely depressed. Temperature shift experiments suggest that a normal level of
production of the affected function was required only during the early (exponential) phase of RNA synthesis.
Analysis of viral polyprotein processing at the nonpermissive temperature revealed that some of the normal
cleavages were not made, most likely as a consequence of the defect in RNA synthesis or as a result of the
concomitant reduction in the level of virally encoded proteases.
The cycle of poliovirus replication was described almost
20 years ago (for a review, see reference 1), but the molec-
ular details of viral RNA synthesis are still not well under-
stood. A major obstacle to further progress has been the
inability to reproduce many aspects of viral replication with
purified factors in vitro (4). Besides the role of viral RNA
polymerase (protein 3D), the role of other viral factors in
RNA synthesis is not clear. Although its exact function is
not known, the 22-amino acid protein VPg (protein 3B) or a
larger VPg-containing precursor polypeptide has been pro-
posed to participate in RNA synthesis (3, 17). This sugges-
tion arose from the observation that VPg is linked to the 5'
end of both plus and minus strands of RNA (12, 13), as well
as to relatively small nascent chains (13). Although free VPg
and uridylylated forms of VPg have been observed in in-
fected cells (8, 18), protein 3AB and two much less abundant
larger polypeptides which contain VPg at their carboxy
termini have also been observed (3, 19). It has been sug-
gested that one of these molecules, most likely 3AB, acts as
a VPg donor during the replication process (3, 17). Protein
3AB may be analogous to the 85,000-dalton adenovirus
protein that acts as a primer for the synthesis of viral DNA
before being truncated to a 50,000-dalton genome-linked
protein (7, 11).
Given the limitations of the biochemical studies, genetic
dissection of the viral genome could provide an insight into
the role of individual polypeptides in the replication process.
The recent generation of an infectious cDNA copy of the
virus (14) now makes it possible to overcome some of the
difficulties of classical genetic approaches and to introduce
well-defined mutations into the viral genome for the first
time. In this report, we describe the physiology of a polio-
virus mutant, designated 3A-2, which contains a lesion in the
3A region of the genome. Studies on the mutant confirm that
this region is involved in viral replication and suggest that 3A
or a 3A-containing polypeptide is required in a much smaller
quantity than is normally produced during the course of a
wild-type infection.
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MATERIALS AND METHODS
Cells and virus stocks. Vero cells (African green monkey
kidney cells) were maintained in Dulbecco modified Eagle
medium supplemented with 10% fetal calf serum (Hazleton).
The method used to produce the wild-type poliovirus type
I (Mahoney strain) stock and the DNA procedures used to
generate and express the 3A-2 plasmid have been described
previously (6). A master stock of mutant virus, used in all
experiments, was produced by expanding a plaque obtained
from a transfection by conventional means on HeLa cells at
39.5°C. HeLa cells were selected for the growth of mutant
stocks, because the virus obtained from transfections had a
phenotype that was closer to that of the wild type at high
temperature on this cell line than on monkey kidney cells.
Measurement of virus yield and viral macromolecular syn-
thesis. The methods used to monitor progeny virus yield and
viral RNA and protein syntheses at various times during a
single cycle of infection have been described (6). Total viral
RNA synthesis was measured as the incorporation of
[14C]uridine into trichloroacetic acid-precipitable material in
the presence of actinomycin D. The synthesis of individual
RNA strands was measured by isolating cytoplasmic RNA
and performing RNA dot blots according to procedures
described previously (9, 15). The BamHI fragment contain-
ing base pairs 670 to 2099 of the poliovirus genome was
cloned into a Riboprobe vector (Promega), and the blots
were probed with transcripts of this fragment synthesized in
vitro with SP6 and T7 promoters.
Viral protein synthesis was analyzed by pulse labeling
infected cells with [35S]methionine and fractionating cell
extracts by gel electrophoresis. In experiments in which
protein synthesis was monitored in cells incubated at 32.5°C,
the pulses lasted for 20 min instead of 10. Immunoprecipita-
tions were performed essentially as described previously (3),
except that samples were not diluted. Cell extracts were first
preabsorbed with normal rabbit serum and then incubated
for 1 to 2 h on ice with an anti-2C antiserum that also
contains some activity against 3D-containing polypeptides
(6). In all cases, proteins were resolved on sodium dodecyl
sulfate (SDS)-12.5% polyacrylamide gels by the method of
Laemmli (10).
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FIG. 1. Sequence of mutant 3A-2. Mutant 3A-2 was generated by using a mutagenesis scheme described previously (6). Restriction digest
and sequence analyses revealed that three base pairs had been inserted into plasmid pSV2-polio at the HinFI site at position 5152 of the
poliovirus cDNA insert. Translation of the mutant RNA was predicted to result in the addition of an extra serine in the 3A region of the
polyprotein as shown. The XbaI-BglII fragment (nucleotides 4886 to 5601) carries the mutant phenotype, and the expected sequence is
indicated.
RESULTS
Generation of mutant 3A-2. Mutant 3A-2 is a single-codon-
insertion mutant that was generated by a method described
previously (6). Briefly, this method involves partial digestion
of an infectious cDNA clone of poliovirus type I (Mahoney
strain) with restriction enzymes that leave three-nucleotide
protruding ends, filling in the ends with DNA polymerase I
(Klenow fragment), and recircularization of the plasmid with
DNA ligase. The position of the insertion was then mapped
by digesting mutant plasmids to completion with the appro-
priate restriction enzyme and determining which recognition
sequence had been lost. In the case of mutant 3A-2, the
HinFI site at position 5152 was observed to be missing (Fig.
1); hence the mutant was predicted to contain an extra amino
acid in the 3A region of the genome. To confirm that the
insertion was the only mutation in the plasmid, an XbaI-
BglII fragment containing the insertion (Fig. 1) was first
exchanged with the equivalent wild-type fragment and
shown to confer the mutant phenotype. Then the mutant
fragment was shown to have a nucleotide sequence which
differed from the wild-type sequence only at the site of the
insertion (Fig. 1).
Growth of 3A-2 in single cycle of infection. When monolay-
ers of Vero cells were transfected with either mutant or
wild-type DNA and incubated at 39.5°C, approximately the
same numbers of plaques were observed on each plate.
When the cells were incubated at 32.5°C, however, virtually
no mutant plaques were seen, even after 1 week. The virus
isolated from transfections was also cold sensitive for plaque
formation on Vero cells. On Vero cell monolayers, an
expanded (master) 3A-2 virus stock yielded plaques at
39.5°C that were large but noticeably smaller than wild-type
plaques produced in parallel (Fig. 2A and B). However,
when monolayers were inoculated with the amount of virus
which yielded approximately 100 plaques at high tempera-
ture and then incubated at 32.5°C until wild-type plaques
were relatively large, only a few pinpoint lesions were
observed (Fig. 2C and D). When 10 or 100 times as much
mutant virus was added, a few larger plaques, presumably
produced by variants which existed in the original popula-
tion or which arose during the plaque assay, were observed
(Fig. 2E and F). The titer of moderate-size and large plaques
was several hundredfold below that observed at 39.5°C.
At 39.5°C, mutant progeny accumulated slightly more
slowly than did wild-type virions, but by the end of the
mutant growth phase (5 to 6 h), 3A-2-infected cells contained
only two to three times fewer progeny than did wild-type-
infected cells. This discrepancy and the slight lag in growth
could explain the difference in the sizes of wild-type and
mutant plaques. If we consider the slower metabolism of
cells at the lower temperature, the kinetics of progeny virus
formation in wild-type-infected cells is very similar to that
observed at high temperature. With mutant-infected cells,
however, several hundredfold less virus was produced by
midcycle (5 to 6 h) than by the equivalent time at high
temperature (3 to 3.5 h). More than 90% of the virus had a
mutant phenotype. By the end of the cycle (8 h), the
discrepancy dropped to less than 50-fold, but most of the
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FIG. 2. Phenotype of mutant 3A-2. In the plaque assay, Vero
cells were inoculated with wild-type or mutant virus from master
,stocks and incubated at 39.5°C (A and B) or 32.5°C (C through F) for
approximately 40 or 60 h, respectively, and then stained. (A and C)
Wild type; (B and D to F) mutant 3A-2. Cells shown in panel E were
inoculated with 10 times as much virus as those shown in panels B
and D, and cells shown in panel F were inoculated with 100 times as
much virus.
titer consisted of variants which gave large plaques at all
temperatures. Presumably, the predominance of these "re-
vertant" viruses was due to their ability to grow much more
rapidly than did the mutant at low temperature. A prelimi-
nary analysis of cDNA produced from two revertant virus
strains indicated that they harbor both the original insertion
and a second-site mutation (in at least one case within 3A)
that suppresses the mutant phenotype (data not shown). The
presence of a second-site mutation is consistent with the
observation that the revertant plaques are slightly smaller
than those produced by the wild-type virus. Given the high
frequency with which revertants arise at low temperature, it
is likely that a single mutation is sufficient to correct the
initial defect.
RNA synthesis in 3A-2-infected cells. In Vero cells, mutant
3A-2 synthesized RNA effectively at the permissive temper-
ature, though not quite as well as did the wild-type virus
(Fig. 3A). The slight impairment of RNA synthesis corre-
lated well with and probably explains the slightly lower yield
of infectious virus in the mutant-infected cells. Another
indication that mutant RNA synthesis was nearly normal
was the fact that the same proportions of full-length single-
stranded and double-stranded RNAs were found in both
mutant- and wild-type-infected cells (data not shown). At the
nonpermissive temperature, very little viral RNA was pro-
duced in 3A-2-infected cells; after 8 h postinfection, a small
amount of RNA, probably produced predominantly by re-
vertant virus, could be detected (Fig. 3A).
To determine whether the 3A-2 defect selectively affected
the synthesis of plus- or minus-strand RNA, cytoplasmic
RNA was isolated from Vero cells that had been infected
with wild-type or mutant virus and then incubated for 3.25
and 4.5 h at 32.5°C. RNA was not isolated at later times
because of the substantial accumulation of revertant virus
after 6 h. The level of each strand was assessed by an RNA
dot blot. In these experiments, the fraction of plus-strand
RNA derived from residual noninfectious input virus was
measured by isolating RNA from cells treated after virus
adsorption with guanidine, a reagent which totally inhibits
viral replication but does not alter cellular metabolism at
millimolar concentrations (1). Significant plus-strand synthe-
sis could be observed in wild-type-infected cells by 3.25 h
postinfection. In contrast, almost no new plus strands had
been made by that time in mutant-infected cells; most of the
RNA was derived from input virus (Fig. 3B). By 4.5 h
postinfection, at least 30-fold more plus strand and at least
20-fold more minus strand had been synthesized in wild-type
cells compared with mutant-infected cells (Fig. 3B and C).
These results indicate that the synthesis of both RNA
strands is affected to approximately the same extent.
The inhibition of host cell transcription was effective,
although slightly delayed, in mutant-infected Vero cells at
the nonpermissive temperature (data not shown). Hence the
lack of viral RNA synthesis does not appear to be related to
a defect in this inhibitory function.
Temperature shift experiments were performed to exam-
ine the reversibility of the 3A-2 defect. When Vero cells
were incubated at 32.5°C for 5 h and then shifted to 39.5°C,
efficient RNA synthesis was observed after the shift (Fig. 4).
Ultimately, the same amount of viral RNA was produced in
these cells as that in cells which had been incubated contin-
uously at high temperature. The linear phase of RNA pro-
duction began within 1 h of the shift; the efficient inhibition
of host cell translation (see below) and transcription and
low-level RNA synthesis during the incubation at 32.5°C
(Fig. 3) probably accounts for this rapid progression to the
second stage of replication.
When cells were incubated at high temperature until the
approximate onset of the linear phase of replication (3 h) and
then shifted to the nonpermissive temperature, RNA synthe-
sis continued normally, as if the shift had not been per-
formed (Fig. 4). Analysis of the RNA produced after the shift
by agarose gel electrophoresis indicated that the product
contained normal proportions of full-length single-stranded
and double-stranded RNAs (data not shown). Hence it is
possible that the 3A-2 defect is in a function which acts only
early in the life cycle of the virus or that the protein made at
39.5°C is stable at low temperature and continues to function
after the shift. Because a large amplification of viral RNA
molecules occurred before the shift, enough templates were
available to engage in a high level of viral protein synthesis
after the shift (data not shown). For this reason, it might also
be argued that even if a small fraction of the relevant protein
is active at low temperature or even if the defective protein
has a low level of residual activity at 32.5°C, enough total
protein was produced to support continued RNA synthesis.
Protein synthesis in mutant-infected cells. Sodium dodecyl
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FIG. 3. Time course of RNA synthesis in wild-type- and mutant 3A-2-infected cells at 39.5 and 32.5°C. (A) Vero cells were infected at an
MOI of 10 and then incubated at 39.5 or 32.5°C. RNA synthesis was measured at different times postinfection as described in the text.
Symbols: [D or O, wild-type RNA synthesis at 39.5 or 32.5°C, respectively; * or O, 3A-2 RNA synthesis at 39.5 or 32.5°C, respectively. To
compensate for the slower metabolism of cells at low temperature, the 32.5°C incubation times have been divided by 1.7 and then aligned to
the scale used for the 39.5°C incubation times. (B and C) Vero cells were infected at an MOI of 5 and incubated at 32.5°C for 3.25 or 4.5 h.
Cytoplasmic RNAs obtained from 2 x 106, 4 x 105, and 8 x 104 cells were loaded into the wells. The probe detected plus-strand (B) or
minus-strand (C) poliovirus RNA. M, Mock infected; 3A-2 -, mutant infected; 3A-2 +, mutant infected and treated with 1 mM guanidine after
virus adsorption; WT, wild type infected.
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sulfate-polyacrylamide gel electrophoresis of extracts of
Vero cells pulse labeled with [35S]methionine showed that
the patterns of proteins produced by wild-type- and 3A-2-
infected cells at 39.5°C were the same (Fig. 5A, lanes 3 to 6).
The cleavage of polyprotein appeared to be normal in the
mutant-infected cells at this temperature. It should be noted
that when poliovirus-infected Vero cells were pulse labeled
after host translation was inhibited, cell extracts reproduc-
ibly contained a number of radioactive polypeptides that
were not observed in extracts prepared from other cell types
(Fig. 5A, compare the HeLa cell extract in lane 1 and the
Vero cell extracts in the other lanes). These polypeptides are
probably degradation products of viral proteins generated by
FIG. 4. RNA synthesis in 3A-2-infected Vero cells after tempera-
ture shift. Vero cells were infected at an MOI of 5 and then
incubated at 39.5 or 32.5°C. After 3 h, half of the dishes incubated at
high temperature were shifted to low temperature; after 5 h, half of
the dishes incubated at low temperature were shifted to high
temperature. The remainder of the dishes were incubated at the
original temperature for the duration of the experiment. RNA
synthesis was measured as described in the legend to Fig. 3A.
Symbols: *, RNA synthesis at 39.5°C; O, RNA synthesis after a
shift down at 3 h postinfection; El, RNA synthesis at 32.5°C; O,
RNA synthesis after a shift up at 5 h postinfection. Temperature
compensation is as described in the legend to Fig. 3.
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FIG. 5. Patterns of protein synthesis in mock-, mutant 3A-2-, and wild-type-infected Vero cells at high or low temperature. (A) Vero cells
were infected at an MOI of 10 and incubated at 39.5 or 32.5°C. Cells were pulse labeled with [35S]methionine at various times, and cell extracts
were prepared. Portions of each extract (20 ,ul) were resolved by gel electrophoresis. Lane 1, Markers (MKR; pulse labeled wild-type-infected
HeLa cell extract); lanes 2 to 6, extracts from mock- (M), mutant- (3A-2), and wild-type- (WT) infected cells incubated at 39.5°C and labeled
at 2.75 (lanes 2, 3, and 5) or 3.75 (lanes 4 and 6) h postinfection; lanes 7 to 11, extracts from mock-, mutant-, and wild-type-infected cells
incubated at 32.5°C and labeled at 4.5 (lanes 7, 8, and 10) or 6 (lanes 9 and 11) h postinfection. (B) Vero cells were infected at an MOI of 10
and incubated at 32.5°C for 4.5 h. The cells were labeled and processed as described for panel A. An anti-2C antiserum was used to
immunoprecipitate proteins from 60 ,ul of mock- and wild-type-infected cell extracts and 180 ,ul of mutant-infected cell extracts. As noted
elsewhere (5), this antiserum also contains some activity against 3D-containing polypeptides. The lanes are marked as described for panel A.
The marker lane contained 20 ,ul of a pulse-labeled wild-type-infected Vero cell extract. Lane 4 was exposed for over 30 times longer than
the rest of the gel.
an enzyme active in the extracts (D. Knipe, personal com-
munication).
Assays which measured [35S]methionine incorporation
into trichloroacetic acid-precipitable material indicated that
at 32.5°C a parallel decline in the rate of protein synthesis
occurred in mutant- and wild-type-infected cells in the first
4.5 h after infection. In the mutant-infected cells, however,
the decline was sometimes slightly slower (data not shown).
Electrophoretic analysis of the proteins produced at 4.5 and
6 h postinfection showed that whereas mainly poliovirus
proteins were synthesized in wild-type-infected cells (Fig.
5A, lanes 10 and 11), there was primarily residual host cell
protein synthesis in mutant-infected cells (Fig. 5A, compare
lane 7 with lanes 8 and 9). This result was not unexpected,
given the very small pool of viral RNA molecules present in
mutant-infected cells.
An extremely low level of poliovirus protein synthesis
(clearly less than 1/50 of the normal level) could be detected
in 3A-2-infected cells at 4.5 h postinfection by immunopre-
cipitation (Fig. SB, lane 4). The pattern of immunoprecipi-
tated proteins indicated that most of the cleavages in the P2
and P3 regions of the polyprotein were made normally (Fig.
SB, compare lanes 3 and 4). In particular, the mutation in 3A
did not appear to prevent the cleavage of 3CD from P3. To
prove that this cleavage was not affected by the low level of
revertants present in the 3A-2-infected cells at 4.5 h postin-
fection, we examined protein synthesis in cells infected at a
multiplicity of infection (MOI) of 100 and treated with 1 mM
guanidine after virus adsorption. In the absence of replica-
tion, viral protein synthesis was readily detectable and very
similar in mutant- and wild-type-infected cells. Although
only a few percentage of cells was likely to contain revertant
RNA molecules under these conditions, 3CD was still
cleaved from P3 as effectively in mutant- as in wild-type-
infected cells (data not shown).
The absence of protein 3D in mutant-infected cells (Fig.
5B, lane 4), however, suggested that the cleavage of 3CD
into 3C and 3D was impaired. A similar absence of 3D has
also been noted in cells infected by the temperature-sensitive
mutant 3NC-202 and has been shown to result from the
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reduced processing of 3CD (P. Sarnow, unpublished
results). The processing problem observed in that case is
probably not due to improper folding of the polyprotein,
because the only lesion is in the 3' noncoding region of the
genome (16). The lack of 3CD cleavage has been attributed
to the inability of the mutant to replicate and to the reduced
level of virally encoded proteases at the nonpermissive
temperature (P. Sarnow, unpublished results). Given these
observations, the unusually low level of 3D in 3A-2-infected
cells at 32.5°C is more likely due to an alteration of polypro-
tein processing common to highly replication-deficient mu-
tants than to a specific defect in protein folding that prevents
excision of 3D from its precursor. The results presented
here, considered with the studies on mutant 3NC-202, sug-
gest that the 3A-2 mutation does not suppress RNA synthe-
sis by perturbing polyprotein processing. Hence the muta-
tion probably disrupts the function of 3A or one of its
precursors rather than a distant segment of the polyprotein.
DISCUSSION
We have begun to examine a poliovirus mutant that
contains a small insertion in the 3A region of the genome.
The primary consequence of the mutation is a severe depres-
sion of both positive- and negative-strand RNA synthesis at
low temperature. Studies on mutant 3A-2 strongly suggest
that at least one 3A-containing polypeptide is involved in
replication. Presumably, because very few viral RNA mol-
ecules were synthesized at low temperature, the yield of
infectious virus was very low. Experiments in which the
temperature was shifted up indicate that productive infection
is not inhibited by maintaining mutant 3A-2 at the nonper-
missive temperature, at least for several hours. Experiments
in which the temperature was shifted down suggest either
that production of the function impaired by the mutation
during the exponential phase of replication is sufficient to
generate a full yield ofRNA or that continuing production of
the function is also required during the linear phase, but at a
level far below that produced during a wild-type infection. In
either case, the implication of these results is that an excess
of the affected function is produced by wild-type virus.
Analysis of the viral proteins present in mutant-infected cells
also suggests that certain cleavages of the polyprotein may
depend on active RNA synthesis.
It is conceivable that a function involved in poliovirus
replication would be required primarily early in the virus life
cycle; a 103-fold amplification of RNA molecules occurs
during the exponential phase of synthesis, whereas only a 5-
to 10-fold increase occurs during the linear phase (2). Al-
though all of the poliovirus proteins are produced throughout
the life cycle, there is some precedent for early and late
functions. The protein which mediates the suppression of
host cell translation must function early and may have no
function at all late in infection. In addition, the encapsidation
of viral RNA molecules seems to occur predominantly late,
after the onset of the linear phase of replication (2).
There is also direct evidence that much more protein is
synthesized during the course of poliovirus infection than is
required for a full round ofRNA synthesis (6). The results of
complementation experiments support the hypothesis that
the wild-type virus overproduces the specific function dis-
rupted by the 3A-2 mutation; a mutant that produces only
about 10% as much RNA and protein as the wild-type virus
can still complement 3A-2 to a moderate extent (5). The
complementation data nevertheless suggest that the muta-
tion in 3A-2 affects a protein which is required in greater than
very small quantities; there is a correlation between the
amount of protein a mutant produces and the extent to which
it can rescue 3A-2.
Finally, the generation of 3A-2 demonstrates that highly
cold-sensitive mutants of poliovirus can be obtained. Only a
small number of very unstable cold-sensitive mutants, com-
pared with scores of stable temperature-sensitive mutants,
have been isolated by classical methods (20). The isolation of
a stable cold-sensitive mutant by insertion mutagenesis
might be an indication that different types of mutations tend
to give rise to different classes of mutants.
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